Nov 13, 2017 05:24 PM IST | Source:

Buy Divis Laboratories; target of Rs 1275: Sharekhan

Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 1275 in its research report dated November 02, 2017.

Broker Research @moneycontrolcom
  • bselive
  • nselive
Todays L/H

Sharekhan's research report on Divis Laboratories

USFDA has informed  Divis Laboratories (Divis) that it will be lifting  Import Alert 66-40 and close out the warning  letter at unit-2 at Vishakhapatnam, which was  re-inspected in September 2017 and was issued  fresh Form 483 with six observations (the  company had filed the response to USFDA in  October 2017).


Taking cue from the recent  developments, we have revised our sales  and earnings estimates for FY2019 and  FY2020 earnings. Hence, we upgrade our  recommendation to Buy with a revised price  target of Rs.1,275 (valuing the stock at 22x  FY2020E earnings vs. earlier 20x) as successful  resolution of import alert and warning letter in a  shor t span of time restores the confidence in the  company and its management.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Follow us on
Available On